ANDREWS Steven W.,ARONOW Sean,BLAKE James F.,BRANDHUBER Barbara J.,COOK Adam,HAAS Julia,JIANG Yutong,KOLAKOWSKI Gabrielle R.,MCFADDIN Elizabeth A.,MCKENNEY Megan L.,MCNULTY Oren T.,METCALF Andrew T.,M
申请号：
SI201730283
公开号：
SI3523301T1
申请日:
2017.10.10
申请国别(地区):
SI
年份:
2020
代理人:
摘要：
and stereoisomers and pharmaceutically acceptable salts or solvates thereof, in which A, B, X1, X2, X3, X4, Ring D, and E have the meanings given in the specification, which are inhibitors of RET kinase and are useful in the treatment and prevention of diseases which can be treated with a RET kinase inhibitor, including RET-associated diseases and disorders.
